Skip to main content

[vc_row][vc_column][vc_single_image image="69243" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Glioblastoma (GBM) is the most aggressive form of brain cancer with a uniformly fatal diagnosis, limited treatment options, and a median survival of less than two years.   Although chimeric antigen receptor (CAR)-T cell immunotherapy has revolutionized the treatment of certain cancers,...

[vc_row][vc_column][vc_single_image image="64614" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]In 1994, Steve Mathews was a picture of strength: an accomplished athlete, Empire State Games medalist, and loving husband and father. When he was diagnosed with glioblastoma, one of the most aggressive and devastating forms of brain cancer, the prognosis...

[vc_row][vc_column width="1/3"][vc_single_image image="61586" img_size="full" alignment="center" css=""][/vc_column][vc_column width="2/3"][vc_column_text css=""]Twenty years ago, Carmen Rice was told to get her affairs in order, she was diagnosed with the deadliest form of brain cancer, glioblastoma. At the time, she was told she had about 6 months to live. In...

[vc_row][vc_column][vc_single_image image="60558" img_size="full" alignment="center"][vc_column_text]The National Foundation for Cancer Research is thrilled to congratulate Dr. Rakesh K. Jain, the A.W. Cook Professor of Radiation Oncology (Tumor Biology) and Director of the E.L. Steele Laboratory, on his achievement of being named the 2023 Proceedings of the National...

[vc_row][vc_column][vc_row_inner css=".vc_custom_1683656310062{padding-top: 15px !important;padding-right: 15px !important;padding-bottom: 15px !important;padding-left: 15px !important;background-color: #cccccc !important;}"][vc_column_inner width="1/3"][vc_single_image image="58010" img_size="full" alignment="center" onclick="link_image"][/vc_column_inner][vc_column_inner width="2/3"][vc_empty_space height="52px"][vc_column_text]Tom & Bernadette, November 2018 in Cienfuegos Cuba Mountain Park. “It was here first symptoms appeared but we did not know it. It was a rocky path...

[vc_row][vc_column][vc_column_text css=""][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Approximately 15,000 Americans will be diagnosed with glioblastoma this year. Although considered a rare cancer, doctors are seeing an increase in cases of the aggressive and deadly brain cancer that’s notoriously hard to treat. A local organization that’s helping enroll brain cancer patients in...

[vc_row][vc_column][vc_single_image image="49165" img_size="full" alignment="center"][vc_column_text]On Wednesday, April 20, 2022, National Foundation for Cancer Research (NFCR) CEO Sujuan Ba and Scientific Board Chairman Web Cavenee joined NBC4 Washington’s Doreen Gentzler to talk about the passing of beloved journalist Wendy Rieger. Rieger passed on Saturday, April 16, 2022, after a battle...

[vc_row][vc_column][vc_video link="https://youtu.be/EUUPkvxzk6Q" align="center"][vc_column_text css=""]Incredibly, 2021 marks the 17th anniversary of Carmen Rice’s survival from Stage 4 Glioblastoma Multiforme (GBM) brain tumor. Originally given six months to live, Carmen beat the odds to become the longest living survivor of the deadliest form of brain cancer. Nothing...

[vc_row][vc_column][vc_single_image image="46166" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor in adults, with a median survival of only about ten months. Unlike low-grade gliomas (grades I and II), which grow slowly, high-grade gliomas (grades III and IV) grow much faster...